Celgene, Penn Pharmaceutical deal

CELG acquired Penn's Penn T division for $110 million in cash. Penn T is the U.K. manufacturer of CELG's Thalomid thalidomide, which is approved to treat erythema nodosum leprosum. CELG said the deal...